IL17A and systemic sclerosis: Furthermore, IL-17A promotes the proliferation, migration, collagen synthesis and secretion of SSc patient-derived dermal vascular smooth muscle cells, resulting in intimal thickening and aggravated vasculopathy and fibrosis [74–76].